These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation. Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Ciotti MT, Hornstein E, Bozzoni I, Presutti C, Centonze D. J Neurosci; 2017 Jan 18; 37(3):546-561. PubMed ID: 28100738 [Abstract] [Full Text] [Related]
3. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Petratos S, Ozturk E, Azari MF, Kenny R, Lee JY, Magee KA, Harvey AR, McDonald C, Taghian K, Moussa L, Mun Aui P, Siatskas C, Litwak S, Fehlings MG, Strittmatter SM, Bernard CC. Brain; 2012 Jun 18; 135(Pt 6):1794-818. PubMed ID: 22544872 [Abstract] [Full Text] [Related]
6. MicroRNA-27a-3p Downregulation Inhibits Inflammatory Response and Hippocampal Neuronal Cell Apoptosis by Upregulating Mitogen-Activated Protein Kinase 4 (MAP2K4) Expression in Epilepsy: In Vivo and In Vitro Studies. Lu J, Zhou N, Yang P, Deng L, Liu G. Med Sci Monit; 2019 Nov 11; 25():8499-8508. PubMed ID: 31710596 [Abstract] [Full Text] [Related]
8. In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination. Marangon D, Boda E, Parolisi R, Negri C, Giorgi C, Montarolo F, Perga S, Bertolotto A, Buffo A, Abbracchio MP, Lecca D. Glia; 2020 Oct 11; 68(10):2001-2014. PubMed ID: 32163190 [Abstract] [Full Text] [Related]
11. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Tham E, Gielen AW, Khademi M, Martin C, Piehl F. Scand J Immunol; 2006 Dec 11; 64(6):609-22. PubMed ID: 17083617 [Abstract] [Full Text] [Related]
14. MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis. De Vito F, Balletta S, Caioli S, Musella A, Guadalupi L, Vanni V, Fresegna D, Bassi MS, Gilio L, Sanna K, Gentile A, Bruno A, Dolcetti E, Buttari F, Pavone L, Furlan R, Finardi A, Perlas E, Hornstein E, Centonze D, Mandolesi G. Curr Neuropharmacol; 2023 Dec 11; 21(12):2567-2582. PubMed ID: 37021418 [Abstract] [Full Text] [Related]
16. Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model. Khan RS, Dine K, Bauman B, Lorentsen M, Lin L, Brown H, Hanson LR, Svitak AL, Wessel H, Brown L, Shindler KS. Sci Rep; 2017 Jan 31; 7():41768. PubMed ID: 28139754 [Abstract] [Full Text] [Related]